Operating profit before deduction of amortization: relmada.com (RLMD)
Relmada Therapeutics (RLMD) is actively developing the innovative drug REL-1017 for the treatment of depression. This chart on GURU.Markets captures the EBITDA_Co dynamics, where the value 0.00 serves as the baseline indicator of operating profit. Patents for esmetadone create a protective barrier for this fast-acting antidepressant. Meanwhile, the company is implementing energy-efficient solutions in its laboratories, adhering to strict ESG environmental standards.
Relmada Therapeutics, Inc. - analytical breakdowns and key metrics (RLMD)
- stock price and consensus target price:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- business debt structure and liquidity details:
Total Debt to Capital Relmada Therapeutics|RLMD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Relmada Therapeutics Inc|RLMD - Company Total Debt|Debt to Book Capital Relmada Therapeutics|RLMD - Company Long-Term Debts|Company Short-Term Loans and Borrowings Relmada Therapeutics|Immediate Liquidity relmada.com
- business earnings and investment ratios data:
RLMD - Company Net Income|Expected Net Income Relmada Therapeutics|RLMD - P/E Multiple|Forward P/E Multiple relmada.com|RLMD - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Relmada Therapeutics|RLMD - Operating profit EBITDA|Net earnings per one share for the last twelve months Relmada Therapeutics|RLMD - Net earnings per share for the last 12 months|Quarterly EPS earnings growth relmada.com|RLMD - Net earnings per share growth this year|Projected earnings per share increase next year Relmada Therapeutics
Fundamental company valuation:Relmada Corp RLMD
Analyzing real cash flow is critical for selecting assets with the maximum margin of safety. This indicator captures net daily operating income excluding non-cash depreciation and amortization expenses, which allows for an assessment of the financial stability of Relmada Therapeutics (RLMD) as it introduces innovative NMDA blockers into psychiatry, while analyzing the EBITDA_Co trend for signs of business overvaluation.
Who Relmada Therapeutics competes with
Biogen Idec - Profit before payment of interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|AXSM: Operating profit EBITDA|ACADIA Pharma (ACAD) - Operating profit EBITDA|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Operating profit before amortization VKTX (Viking Therapeutics Corp)|Operating profit EBITDA SUPN|Operating profit EBITDA catalystpharma.com (CPRX)|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Amylyx Corp - Company profit before taxes, interest and amortization|TRVI: Operating profit EBITDA|praxismedicines.com - Income before deduction of interest, taxes and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Profit before interest, taxes and amortization CeriBell Inc CBLL|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACIU|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Corp (NMRA)|Operating profit before deduction of amortization SCLX|Operating profit EBITDA tevogen.com|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Company profit before taxes, interest and amortization CGTX|Operating profit EBITDA IKT (Inhibikase)|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|vistagen.com (VTGN) - Profit before payment of interest, taxes and amortization|OVID - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Acumen Pharma|CRVO: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alterity Therapeutics (ATHE)|Profit before payment of interest, taxes and amortization CLNN (clene.com)|Profit before payment of interest, taxes and amortization PepGen PEPG|JUNS - Operating profit before deduction of amortization|Annovis Bio Corp - Operating profit EBITDA|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|Operating profit before amortization KLTO|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Reviva Pharmaceuticals Holdings Inc. RVPH|Operating profit before deduction of amortization MTVA (MetaVia Inc)|Operating profit EBITDA NeurAxis Inc (NRXS)|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Income before deduction of interest, taxes and amortization PASG|NEUP - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Minerva Neurosciences Inc|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Cyclerion CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Profit before payment of interest, taxes and amortization KTTA (pasitheaclinics.com)|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI - Operating profit before deduction of amortization|Brainstorm Cell - Operating profit EBITDA|CARA - Operating profit EBITDA|CHRO: Operating profit EBITDA|Operating profit before amortization ELYM|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Operating profit EBITDA Longboard|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAGE (Sage Therapeutics Inc.)|Neurotrope - Operating profit EBITDA|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
